Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Top Cited Papers
- 28 February 2020
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 248, 117477
- https://doi.org/10.1016/j.lfs.2020.117477
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C VirusAntimicrobial Agents and Chemotherapy, 2012
- Safety and Pharmacokinetics of IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor of Hepatitis C Virus, in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2011
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977Journal of Biological Chemistry, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elementsJournal of Molecular Modeling, 2007
- Announcing the worldwide Protein Data BankNature Structural & Molecular Biology, 2003
- Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha InterferonAntimicrobial Agents and Chemotherapy, 2000
- AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMRJournal of Biomolecular NMR, 1996
- Deviations from Standard Atomic Volumes as a Quality Measure for Protein Crystal StructuresJournal of Molecular Biology, 1996